期刊文献+

采用国际生活质量量表评价中医药治疗老年晚期非小细胞肺癌的疗效 被引量:36

Assessment of Therapeutic Efficacy on Treating Advanced Non-small Cell Lung Cancer in the Aged by Chinese Medicine Adopting the International Questionnaire of Quality of Life
下载PDF
导出
摘要 目的采用国际生活质量量表评价中医药治疗老年晚期非小细胞肺癌(non-small cell lung cancer,NSCLC)的疗效。方法将91例老年晚期NSCLC患者随机分成中医组(31例)、化疗组(30例)及中医加化疗组(30例)。中医组采用中药汤剂口服加中药注射剂静脉滴注治疗方法;化疗组单纯接受化疗方案治疗;中医加化疗组采用化疗方案治疗的同时服用中药汤剂,28天为1个周期,均治疗2个周期。分别于治疗前、第2个治疗周期的第10天及第28天采用欧洲癌症研究与治疗组织肺癌生活质量量表(EORTC QLQ-LC43)进行评价。结果经2个周期治疗后,中医组和中医加化疗组患者躯体功能、角色功能、情绪功能、社会功能及总健康状况领域评分高于化疗组,气促、咳嗽、疲倦、失眠、食欲丧失及便秘症状评分低于化疗组,差异均有统计学意义(P<0·05,P<0·01)。结论中医药治疗可减轻老年晚期NSCLC患者的临床症状,改善患者生活质量。 Objective To assess the therapeutic efficacy of treating advanced non-small cell lung cancer(NSCLC) in the aged by Chinese medicine(CM) adopting the international questionnaire of quality of life(QOL).Methods 91 aged patients with advanced NSCLC were randomly assigned to three groups.There were 31 in the CM group(Group Ⅰ),30 in the chemotherapy group(Group Ⅱ),and 30 in the CM and chemotherapy combination group(Group Ⅲ).Oral administration of CM decoction and intravenous dripping of Chinese patent medicine was given to those in Group Ⅰ.Patients in Group Ⅱ received chemotherapeutic protocol alone.Patients in Group Ⅲ received chemotherapeutic protocol while orally taking CM decoction.Twenty-eight days were taken as one therapeutic course,and two courses in total.Assessment was performed using European Organization for Research and Treatment of Lung Cancer Quality of Life Questionnaire LC-43(EORTC QLQ-LC43) before treatment,the 10th day of the second therapeutic course,and the 28th day of the second therapeutic course,respectively.Results After two therapeutic courses of treatment,compared with Group Ⅱ,better effects were obtained in Group Ⅰ and Group Ⅲ in the aspects of the physical function,roles function,emotional functions,social functions,general health state,and short breath,cough,fatigue,insomnia,poor appetite,and constipation(P0.05,P0.01).Conclusions CM therapy could relieve the clinical symptoms of aged patients with advanced NSCLC and improve their QOL.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2011年第7期873-879,共7页 Chinese Journal of Integrated Traditional and Western Medicine
基金 民政部中国老年学学会科研课题(No.2008-47-2-41)
关键词 中医药疗法 晚期非小细胞肺癌 老年患者 生活质量 Chinese medicine therapy advanced non-small cell lung cancer aged patient quality of life
  • 相关文献

参考文献8

二级参考文献22

  • 1卢冰,欧阳伟炜,付和谊,王仁敏.艾迪注射液辅助治疗晚期非小细胞肺癌对生活质量的临床研究[J].肿瘤防治杂志,2004,11(8):895-896. 被引量:7
  • 2Beitz J,Gnecco C,Justice R.Quality of life end points in cancer clinical trials:the US Food and Drug Administration perspective[J].J Natl Cancer Inst Monogr,1996,20:7-9.
  • 3Johnson JR,Temple R.Food and drug administration requirements for approval of new drugs[J].Cancer Treat Rep,1985,69:1155-1157.
  • 4Montazeri A,Charles R,James M,et al.Quality of life with lung cancer[J].Chest,1998,113(2):467-480.
  • 5中国抗癌协会编.新编恶性肿瘤诊治规范,第九分册[M].北京:中国协和医科大学出版社,1997:737-781.
  • 6Beitz J,Gnecco C,Justice R.Quality of life end points incancer clinical trials:the US Food and Drug Administration perspective.J Natl Cancer Inst Monogr 1996 ;20:7-9.
  • 7中国抗癌协会编.新编常见恶性肿瘤诊治规范(第九分册)[M].北京:中国协和医科大学出版社,1997.737-781.
  • 8.国际抗癌联盟AJCC/UICC肺癌分期(97国际肺癌分期)标准[A].见:周际昌主编.实用肿瘤内科学[C].北京:人民卫生出版社,1999.23.
  • 9汤钊猷.现代肿瘤学(第2版)[M].上海:上海医科大学出版社,1999.22.
  • 10Frost MH,Bonomi AE,Ferrans CE,et al.Patient,clinician,and population perspectives on determination of the clinical significance of quality-of-life scores.Mayo Clin Proc 2002;77(5):488-494.

共引文献100

同被引文献420

引证文献36

二级引证文献216

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部